Aschraf El-Essawi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aschraf El-Essawi has a total of 267 co-authors. Here are the top co-authors by number of shared publications:
Wolfgang Harringer
Department of Thoracic and Cardiovascular surgery, Braunschweig Municipal Hospital Germany
9 shared publications- Wolfgang Harringer
Klinikum Braunschweig
9 shared publications I. Breitenbach
Klinikum Braunschweig
5 shared publicationsIngo Breitenbach
Department of Thoracic and Cardiovascular surgery, Braunschweig Municipal Hospital Germany
5 shared publications- Ingo Kutschka
Department of Thoracic and Cardiovascular Surgery, University Medical Center Göttingen
5 shared publications - Niels Voigt
DZHK (German Centre for Cardiovascular Research), Partner Site Lower Saxony, Göttingen, Germany
5 shared publications
Latest Publications
- Open Access
- 2 April 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (8) , 1037-1054
Mass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients
Aims: Pulmonary veins in the left atrium (LA) are well-established as a critical site for the initiation of atrial fibrillation (AF). Emerging evidence suggests that in persistent AF (persAF), AF triggers may extend beyond LA. However, the extent to which AF-associated remodelling involves the right atrium (RA) in persAF remains a subject of debate. To address this, we employed a proteomic approach aiming at investigating AF-associated remodelling in the RA relative to the LA in persAF. Methods and results: RA and LA samples were obtained from sinus rhythm (SR) patients, patients with persAF undergoing open-heart surgery, and non-failing donor hearts rejected for transplantation. A reference spectral library representing the human cardiac proteome was employed to assess the RA and LA proteomes by data-independent acquisition mass spectrometry. Protein levels were quantified by immunoblotting of human atrial tissue. Plasma levels of NT-proANP and NT-proBNP were measured in SR and persAF patients. Fibrosis levels were quantified in paraffin-embedded sections using Masson-Goldner trichrome staining. A spectral library representing 13 539 human proteins was generated from five anatomical regions of five independent donor hearts. In persAF RA, we observed marked myolysis, excessive extracellular matrix deposition and a prominent similarity to the failing ventricular proteome, all comparable to persAF LA. Although significant proteomic differences were observed between the RA and LA from SR patients, a comparison of RA and LA proteomes in persAF patients revealed proteome homogenization between the two atrial chambers. RA contributes to this homogenization by losing RA-specific markers, while gaining LA-specific markers. Conclusion: Our findings suggest that RA undergoes comparable AF-associated remodelling to LA, contributing to atrial proteome unification which represents a hallmark of persAF.
- 2 April 2026
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 122 (8) , 1037-1054
Open AccessMass spectrometric proteome profiling using a deep spectral library reveals homogenization of right and left atrial proteomes in persistent atrial fibrillation patients
Aims: Pulmonary veins in the left atrium (LA) are well-established as a critical site for the initiation of atrial fibrillation (AF). Emerging evidence suggests that in persistent AF (persAF), AF triggers may extend beyond LA. However, the extent to which AF-associated remodelling involves the right atrium (RA) in persAF remains a subject of debate. To address this, we employed a proteomic approach aiming at investigating AF-associated remodelling in the RA relative to the LA in persAF. Methods and results: RA and LA samples were obtained from sinus rhythm (SR) patients, patients with persAF undergoing open-heart surgery, and non-failing donor hearts rejected for transplantation. A reference spectral library representing the human cardiac proteome was employed to assess the RA and LA proteomes by data-independent acquisition mass spectrometry. Protein levels were quantified by immunoblotting of human atrial tissue. Plasma levels of NT-proANP and NT-proBNP were measured in SR and persAF patients. Fibrosis levels were quantified in paraffin-embedded sections using Masson-Goldner trichrome staining. A spectral library representing 13 539 human proteins was generated from five anatomical regions of five independent donor hearts. In persAF RA, we observed marked myolysis, excessive extracellular matrix deposition and a prominent similarity to the failing ventricular proteome, all comparable to persAF LA. Although significant proteomic differences were observed between the RA and LA from SR patients, a comparison of RA and LA proteomes in persAF patients revealed proteome homogenization between the two atrial chambers. RA contributes to this homogenization by losing RA-specific markers, while gaining LA-specific markers. Conclusion: Our findings suggest that RA undergoes comparable AF-associated remodelling to LA, contributing to atrial proteome unification which represents a hallmark of persAF.
- 24 March 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 144 (6) , 1391-1399
Recirculation Quantified by Trans–Extracorporeal Membrane Oxygenation Thermodilution to Predict Mixed Venous Oxygenation during Veno-venous Extracorporeal Membrane Oxygenation: An In Vivo Porcine Study
Background: Recirculation is a major contributor to refractory hypoxemia during veno-venous extracorporeal membrane oxygenation (V-V ECMO), yet it remains difficult to measure at the bedside. In an animal study, the authors applied the trans–extracorporeal membrane oxygenation thermodilution (TET) to quantify the phenomenon, identify its determinants, and estimate the mixed venous oxygenation noninvasively. Methods: Eight pigs (65 ± 3 kg) were anesthetized and cannulated for femoral–jugular V-V ECMO. Acute respiratory distress syndrome was induced using oleic (n = 4) or hydrochloric acid (n = 4) targeting a Pa o 2 /inspired oxygen fraction of 150 mmHg. The experiment lasted 24 h, with serial measurements of blood gases, hemodynamics, and respiratory mechanics. TET was performed by injecting a bolus of cold saline downstream the membrane lung and by recording the resulting temperature changes in the drainage and return cannulas. Recirculation was calculated as the ratio of the areas under the temperature–time curves. The determinants of the recirculation were analyzed with mixed linear models, including a random intercept. The measured recirculation was incorporated in a series of mass transfer equations to estimate the mixed venous oxygen content and saturation. Results: Median recirculation was 7.4% [interquatile range, 1.1 to 22.0] and presented large intersubject variability. In 55% of measurements, recirculation was less than 10% (minimal recirculation). In the remaining measurements, the recirculation measured 27.4 [15.0 to 43.5; significant recirculation]. The ratio of extracorporeal blood flow to cardiac output measured 0.63 [0.55 to 0.72] and was the only physiologic factor correlated with recirculation (overall Pearson correlation coefficient, r = 0.67; in the significant recirculation, r = 0.81). The distance between the tip of the cannulas was, in our setup, nonsignificantly associated to the recirculation ( P = 0.74). An increased recirculation was modestly associated with a decreased mixed venous P o 2 ( r = –0.37). The noninvasive estimation of the mixed venous oxygenation was highly accurate ( r = 0.98, bias plus 0.48 ml/100 ml for the oxygen content; r = 0.98, bias plus 4% for saturation). Conclusions: TET is a promising technique to measure the recirculation during V-V ECMO. Increasing the blood flow does not always lead to an improvement in oxygenation given the tight relationship between ratio of extracorporeal blood flow to cardiac output and recirculation. The proposed numerical method allows the noninvasive estimation of the mixed venous oxygenation without the need of a pulmonary artery catheter.
- 24 March 2026
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 144 (6) , 1391-1399
Recirculation Quantified by Trans–Extracorporeal Membrane Oxygenation Thermodilution to Predict Mixed Venous Oxygenation during Veno-venous Extracorporeal Membrane Oxygenation: An In Vivo Porcine Study
Background: Recirculation is a major contributor to refractory hypoxemia during veno-venous extracorporeal membrane oxygenation (V-V ECMO), yet it remains difficult to measure at the bedside. In an animal study, the authors applied the trans–extracorporeal membrane oxygenation thermodilution (TET) to quantify the phenomenon, identify its determinants, and estimate the mixed venous oxygenation noninvasively. Methods: Eight pigs (65 ± 3 kg) were anesthetized and cannulated for femoral–jugular V-V ECMO. Acute respiratory distress syndrome was induced using oleic (n = 4) or hydrochloric acid (n = 4) targeting a Pa o 2 /inspired oxygen fraction of 150 mmHg. The experiment lasted 24 h, with serial measurements of blood gases, hemodynamics, and respiratory mechanics. TET was performed by injecting a bolus of cold saline downstream the membrane lung and by recording the resulting temperature changes in the drainage and return cannulas. Recirculation was calculated as the ratio of the areas under the temperature–time curves. The determinants of the recirculation were analyzed with mixed linear models, including a random intercept. The measured recirculation was incorporated in a series of mass transfer equations to estimate the mixed venous oxygen content and saturation. Results: Median recirculation was 7.4% [interquatile range, 1.1 to 22.0] and presented large intersubject variability. In 55% of measurements, recirculation was less than 10% (minimal recirculation). In the remaining measurements, the recirculation measured 27.4 [15.0 to 43.5; significant recirculation]. The ratio of extracorporeal blood flow to cardiac output measured 0.63 [0.55 to 0.72] and was the only physiologic factor correlated with recirculation (overall Pearson correlation coefficient, r = 0.67; in the significant recirculation, r = 0.81). The distance between the tip of the cannulas was, in our setup, nonsignificantly associated to the recirculation ( P = 0.74). An increased recirculation was modestly associated with a decreased mixed venous P o 2 ( r = –0.37). The noninvasive estimation of the mixed venous oxygenation was highly accurate ( r = 0.98, bias plus 0.48 ml/100 ml for the oxygen content; r = 0.98, bias plus 4% for saturation). Conclusions: TET is a promising technique to measure the recirculation during V-V ECMO. Increasing the blood flow does not always lead to an improvement in oxygenation given the tight relationship between ratio of extracorporeal blood flow to cardiac output and recirculation. The proposed numerical method allows the noninvasive estimation of the mixed venous oxygenation without the need of a pulmonary artery catheter.
- Open Access
- 25 February 2026
- Published by Springer Nature in Journal of Anesthesia, Analgesia and Critical Care
- Vol. 6 (1)
The international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patients
Introduction: Blood purification techniques are being investigated as adjunctive options in critically ill patients not only to treat severe inflammation but also to remove harmful substances such as myoglobin in rhabdomyolysis. Yet, the available evidence is limited, and further research is needed to clarify their clinical benefits. Methods: The international prospective COSMOS Registry (NCT05146336, 23 Nov 2021) tracks CytoSorb® (CS) utilization patterns and outcomes in critical care settings. Clinical assessment was performed before, during, and after CS treatment, with a 90-day follow-up. Device-related adverse effects were reported by investigators as the safety evaluation. Data were analyzed according to a pre-specified statistical plan using descriptive statistics and paired tests to compare pre- and post-treatment values, with subgroup and safety analyses performed. Results: A total of 300 adult patients (30.3% female, mean age 59 ± 15 years) from 22 sites were included in this analysis. The most common indications for CS therapy (multiple indications possible per patient) were septic shock (48.3%), rhabdomyolysis (12.8%), cardiogenic shock (11.5%), liver failure (11.5%), and acute respiratory distress syndrome (ARDS; 5.0%). On average, each patient received 3.3 ± 3.3 adsorbers, with 27.9% of patients receiving 4 or more adsorbers. CS was integrated in conjunction with kidney replacement therapy (75.6%), standalone hemoperfusion (7.1%), intermittent hemodialysis (IHD; 10.6%), extracorporeal membrane oxygenation (ECMO; 3.9%), and sustained low-efficiency daily dialysis (SLEDD; 4.9%). At baseline, median (interquartile range, IQR) APACHE II and SOFA scores were 24 [18, 30] and 12 [9, 15], respectively. Fluid balance improved from +1675 [141, 3348] mL pre-CS to +115 [−1100, 1495] mL post-CS, and norepinephrine requirements decreased from 0.21 [0.09, 0.40] µg/kg/min to 0.08 [0.02, 0.22] µg/kg/min ( p < 0.0001 for both). Ratio of partial pressure of oxygen in arterial blood to the fraction of inspiratory oxygen concentration (P/F ratio) improved from 120 [72, 208] to 176 [115, 255] ( p < 0.0001). Platelet counts decreased from 123 [76, 185] to 72 [42, 118] × 10 9 /L ( p < 0.0001), while albumin levels remained stable from 2.6 [2.3, 3.1] to 2.5 [2.3, 3.0] g/dL ( p = 0.112). ICU mortality was 33.1%, which was lower than mortality estimates historically associated with comparable APACHE II and SOFA scores. No serious adverse effects related to the device or device deficiencies were reported. Conclusions: Real-world CytoSorb® use as part of standard care in critically ill patients was associated with improvements in several clinical and laboratory parameters; however, these findings should be interpreted cautiously given the observational design and absence of a control group. Observed mortality was lower than mortality estimates historically associated with established severity scores.
- 25 February 2026
- Published by Springer Nature in Journal of Anesthesia, Analgesia and Critical Care
- Vol. 6 (1)
Open AccessThe international, prospective COSMOS (CytOSorb® TreatMent Of Critically Ill PatientS) Registry: results from the first 300 patients
Introduction: Blood purification techniques are being investigated as adjunctive options in critically ill patients not only to treat severe inflammation but also to remove harmful substances such as myoglobin in rhabdomyolysis. Yet, the available evidence is limited, and further research is needed to clarify their clinical benefits. Methods: The international prospective COSMOS Registry (NCT05146336, 23 Nov 2021) tracks CytoSorb® (CS) utilization patterns and outcomes in critical care settings. Clinical assessment was performed before, during, and after CS treatment, with a 90-day follow-up. Device-related adverse effects were reported by investigators as the safety evaluation. Data were analyzed according to a pre-specified statistical plan using descriptive statistics and paired tests to compare pre- and post-treatment values, with subgroup and safety analyses performed. Results: A total of 300 adult patients (30.3% female, mean age 59 ± 15 years) from 22 sites were included in this analysis. The most common indications for CS therapy (multiple indications possible per patient) were septic shock (48.3%), rhabdomyolysis (12.8%), cardiogenic shock (11.5%), liver failure (11.5%), and acute respiratory distress syndrome (ARDS; 5.0%). On average, each patient received 3.3 ± 3.3 adsorbers, with 27.9% of patients receiving 4 or more adsorbers. CS was integrated in conjunction with kidney replacement therapy (75.6%), standalone hemoperfusion (7.1%), intermittent hemodialysis (IHD; 10.6%), extracorporeal membrane oxygenation (ECMO; 3.9%), and sustained low-efficiency daily dialysis (SLEDD; 4.9%). At baseline, median (interquartile range, IQR) APACHE II and SOFA scores were 24 [18, 30] and 12 [9, 15], respectively. Fluid balance improved from +1675 [141, 3348] mL pre-CS to +115 [−1100, 1495] mL post-CS, and norepinephrine requirements decreased from 0.21 [0.09, 0.40] µg/kg/min to 0.08 [0.02, 0.22] µg/kg/min ( p < 0.0001 for both). Ratio of partial pressure of oxygen in arterial blood to the fraction of inspiratory oxygen concentration (P/F ratio) improved from 120 [72, 208] to 176 [115, 255] ( p < 0.0001). Platelet counts decreased from 123 [76, 185] to 72 [42, 118] × 10 9 /L ( p < 0.0001), while albumin levels remained stable from 2.6 [2.3, 3.1] to 2.5 [2.3, 3.0] g/dL ( p = 0.112). ICU mortality was 33.1%, which was lower than mortality estimates historically associated with comparable APACHE II and SOFA scores. No serious adverse effects related to the device or device deficiencies were reported. Conclusions: Real-world CytoSorb® use as part of standard care in critically ill patients was associated with improvements in several clinical and laboratory parameters; however, these findings should be interpreted cautiously given the observational design and absence of a control group. Observed mortality was lower than mortality estimates historically associated with established severity scores.
- Open Access
- 7 November 2025
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 137 (11) , 1333-1352
Impaired Atrial Mitochondrial Calcium Handling in Patients With Atrial Fibrillation
BACKGROUND: Mitochondrial calcium (Ca 2+ ) is a key regulator of cardiac energetics by stimulating the tricarboxylic acid cycle during elevated workload. Atrial fibrillation (AF) is associated with a reduction in cytosolic Ca 2+ transient amplitude, but its effect on mitochondrial Ca 2+ handling and cellular redox state has not been explored. METHODS: Cardiac myocytes isolated from patient-derived right atrial biopsies were subjected to workload transitions using patch-clamp stimulation and β-adrenergic stimulation (isoproterenol). In conjunction, nicotinamide adenine dinucleotide (phosphate)/flavin adenine dinucleotide (NAD[P]H/FAD) autofluorescence, cytosolic and mitochondrial [Ca 2+ ] were monitored using epifluorescence microscopy. Sarcoplasmic reticulum and mitochondria were imaged using electron microscopy and tomography and stimulated emission depletion microscopy. The effects of the mitochondrial Ca 2+ uptake enhancer ezetimibe on proarrhythmic activity in atrial myocytes and on AF burden in patients were investigated. RESULTS: Mitochondrial Ca 2+ accumulation during increased workload was blunted in AF, and was associated with impaired regeneration of nicotinamide adenine dinucleotide and flavin adenine dinucleotide. Nanoscale imaging revealed spatial disorganization of sarcoplasmic reticulum and mitochondria, associated with microtubule destabilization. This was confirmed in human induced pluripotent stem cell–derived cardiac myocytes, where treatment with the microtubule destabilizer nocodazole displaced mitochondria and increased proarrhythmic Ca 2+ sparks, which were rescued by MitoTEMPO. Ezetimibe also reduced the occurrence of arrhythmogenic Ca 2+ release events both in AF myocytes and nocodazole-treated human induced pluripotent stem cell–derived cardiac myocytes. Retrospective patient analysis also revealed a reduced AF burden in patients on ezetimibe treatment. CONCLUSIONS: Mitochondrial Ca 2+ uptake and accumulation are impaired in atrial myocytes from patients with AF. The disturbed spatial association between sarcoplasmic reticulum and mitochondria driven by destabilized microtubules may underlie impaired Ca 2+ transfer in AF. Enhancing mitochondrial Ca 2+ uptake potentially protects against arrhythmogenic events.
- 7 November 2025
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 137 (11) , 1333-1352
Open AccessImpaired Atrial Mitochondrial Calcium Handling in Patients With Atrial Fibrillation
BACKGROUND: Mitochondrial calcium (Ca 2+ ) is a key regulator of cardiac energetics by stimulating the tricarboxylic acid cycle during elevated workload. Atrial fibrillation (AF) is associated with a reduction in cytosolic Ca 2+ transient amplitude, but its effect on mitochondrial Ca 2+ handling and cellular redox state has not been explored. METHODS: Cardiac myocytes isolated from patient-derived right atrial biopsies were subjected to workload transitions using patch-clamp stimulation and β-adrenergic stimulation (isoproterenol). In conjunction, nicotinamide adenine dinucleotide (phosphate)/flavin adenine dinucleotide (NAD[P]H/FAD) autofluorescence, cytosolic and mitochondrial [Ca 2+ ] were monitored using epifluorescence microscopy. Sarcoplasmic reticulum and mitochondria were imaged using electron microscopy and tomography and stimulated emission depletion microscopy. The effects of the mitochondrial Ca 2+ uptake enhancer ezetimibe on proarrhythmic activity in atrial myocytes and on AF burden in patients were investigated. RESULTS: Mitochondrial Ca 2+ accumulation during increased workload was blunted in AF, and was associated with impaired regeneration of nicotinamide adenine dinucleotide and flavin adenine dinucleotide. Nanoscale imaging revealed spatial disorganization of sarcoplasmic reticulum and mitochondria, associated with microtubule destabilization. This was confirmed in human induced pluripotent stem cell–derived cardiac myocytes, where treatment with the microtubule destabilizer nocodazole displaced mitochondria and increased proarrhythmic Ca 2+ sparks, which were rescued by MitoTEMPO. Ezetimibe also reduced the occurrence of arrhythmogenic Ca 2+ release events both in AF myocytes and nocodazole-treated human induced pluripotent stem cell–derived cardiac myocytes. Retrospective patient analysis also revealed a reduced AF burden in patients on ezetimibe treatment. CONCLUSIONS: Mitochondrial Ca 2+ uptake and accumulation are impaired in atrial myocytes from patients with AF. The disturbed spatial association between sarcoplasmic reticulum and mitochondria driven by destabilized microtubules may underlie impaired Ca 2+ transfer in AF. Enhancing mitochondrial Ca 2+ uptake potentially protects against arrhythmogenic events.
- Open Access
- 9 September 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (13) , 1609-1621
Cytosolic calcium handling signature: integration with clinical predictors enhances prediction of post-operative atrial fibrillation
Background and Aims: Atrial fibrillation (AF) is a prevalent complication after cardiac surgery, worsening patient outcomes. Considering the established role of Ca2+-handling abnormalities in AF pathogenesis, this study aimed to evaluate if integrating cytosolic Ca2+-handling measurements with clinical risk factors enhances the risk prediction of post-operative AF. Methods: Clinical data from 558 patients undergoing cardiac surgery without pre-existing AF from two centres were analysed. From 94 of these patients, atrial cardiomyocytes were isolated from collected right atrial appendages and Ca2+ handling (L-type Ca2+ current, intracellular Ca2+ concentration) was assessed using patch-clamp. The predictive performance of combining both clinical and single-cell Ca2+ handling parameters was tested using sequential feature selection and logistic regression models. Results: Single-cell Ca2+-handling parameters through cluster analysis correlated with post-operative AF development and several cardiac diseases. Integration of Ca2+-handling parameters into a new post-operative AF risk prediction model improved its predictive accuracy by increasing the areas under the receiver operating characteristic (ROC) curves from 0.69 to 0.71 in the training and 0.76 to 0.79 in the validation cohort. Systolic Ca2+ level, along with clinical parameters such as age, left atrial dilatation, valvular heart disease, impaired renal function, and serum magnesium, was identified as an independent risk factor for post-operative AF. Additionally, a predictive score for AF occurrence at discharge and during rehabilitation has been developed, with area under the curve (AUC) values of 0.84 and 0.71, respectively. Incorporating the occurrence of AF during the immediate post-operative period as an additional predictor significantly enhanced the prediction of AF at discharge, achieving an AUC value of 0.94. Conclusions: Integrating cellular Ca2+ handling signature with clinical predictors improves the prediction of post-operative AF, highlighting the potential of incorporating functional cellular data into clinical risk models.
- 9 September 2025
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (13) , 1609-1621
Open AccessCytosolic calcium handling signature: integration with clinical predictors enhances prediction of post-operative atrial fibrillation
Background and Aims: Atrial fibrillation (AF) is a prevalent complication after cardiac surgery, worsening patient outcomes. Considering the established role of Ca2+-handling abnormalities in AF pathogenesis, this study aimed to evaluate if integrating cytosolic Ca2+-handling measurements with clinical risk factors enhances the risk prediction of post-operative AF. Methods: Clinical data from 558 patients undergoing cardiac surgery without pre-existing AF from two centres were analysed. From 94 of these patients, atrial cardiomyocytes were isolated from collected right atrial appendages and Ca2+ handling (L-type Ca2+ current, intracellular Ca2+ concentration) was assessed using patch-clamp. The predictive performance of combining both clinical and single-cell Ca2+ handling parameters was tested using sequential feature selection and logistic regression models. Results: Single-cell Ca2+-handling parameters through cluster analysis correlated with post-operative AF development and several cardiac diseases. Integration of Ca2+-handling parameters into a new post-operative AF risk prediction model improved its predictive accuracy by increasing the areas under the receiver operating characteristic (ROC) curves from 0.69 to 0.71 in the training and 0.76 to 0.79 in the validation cohort. Systolic Ca2+ level, along with clinical parameters such as age, left atrial dilatation, valvular heart disease, impaired renal function, and serum magnesium, was identified as an independent risk factor for post-operative AF. Additionally, a predictive score for AF occurrence at discharge and during rehabilitation has been developed, with area under the curve (AUC) values of 0.84 and 0.71, respectively. Incorporating the occurrence of AF during the immediate post-operative period as an additional predictor significantly enhanced the prediction of AF at discharge, achieving an AUC value of 0.94. Conclusions: Integrating cellular Ca2+ handling signature with clinical predictors improves the prediction of post-operative AF, highlighting the potential of incorporating functional cellular data into clinical risk models.
- 1 September 2025
- Published by Springer Nature in Zeitschrift für Herz-,Thorax- und Gefäßchirurgie
- p. 1-15
Protokolle der Enhanced Recovery After Surgery in der Herzchirurgie
- 1 September 2025
- Published by Springer Nature in Zeitschrift für Herz-,Thorax- und Gefäßchirurgie
- p. 1-15
Protokolle der Enhanced Recovery After Surgery in der Herzchirurgie
- 27 November 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (6) , 1527-1528
Letter re: The COMICS trial: Randomization to MiECC significantly decreases serious adverse events
- 27 November 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (6) , 1527-1528
Letter re: The COMICS trial: Randomization to MiECC significantly decreases serious adverse events
- Open Access
- 13 August 2024
- Published by Wolters Kluwer Health in Circulation
- Vol. 150 (7) , 544-559
Impaired Intracellular Calcium Buffering Contributes to the Arrhythmogenic Substrate in Atrial Myocytes From Patients With Atrial Fibrillation
BACKGROUND: Alterations in the buffering of intracellular Ca 2+ , for which myofilament proteins play a key role, have been shown to promote cardiac arrhythmia. It is interesting that although studies report atrial myofibrillar degradation in patients with persistent atrial fibrillation (persAF), the intracellular Ca 2+ buffering profile in persAF remains obscure. Therefore, we aimed to investigate the intracellular buffering of Ca 2+ and its potential arrhythmogenic role in persAF. METHODS: Transmembrane Ca 2+ fluxes (patch-clamp) and intracellular Ca 2+ signaling (fluo-3-acetoxymethyl ester) were recorded simultaneously in myocytes from right atrial biopsies of sinus rhythm (Ctrl) and patients with persAF, alongside human atrial subtype induced pluripotent stem cell–derived cardiac myocytes (iPSC-CMs). Protein levels were quantified by immunoblotting of human atrial tissue and induced pluripotent stem cell–derived cardiac myocytes. Mouse whole heart and atrial electrophysiology were measured on a Langendorff system. RESULTS: Cytosolic Ca 2+ buffering was decreased in atrial myocytes of patients with persAF because of a depleted amount of Ca 2+ buffers. In agreement, protein levels of selected Ca 2+ binding myofilament proteins, including cTnC (cardiac troponin C), a major cytosolic Ca 2+ buffer, were significantly lower in patients with persAF. Small interfering RNA (siRNA)–mediated knockdown of cTnC (si-cTNC) in atrial iPSC-CM phenocopied the reduced cytosolic Ca 2+ buffering observed in persAF. Si-cTnC treated atrial iPSC-CM exhibited a higher predisposition to spontaneous Ca 2+ release events and developed action potential alternans at low stimulation frequencies. Last, indirect reduction of cytosolic Ca 2+ buffering using blebbistatin in an ex vivo mouse whole heart model increased vulnerability to tachypacing-induced atrial arrhythmia, validating the direct mechanistic link between impaired cytosolic Ca 2+ buffering and atrial arrhythmogenesis. CONCLUSIONS: Our findings suggest that loss of myofilament proteins, particularly reduced cTnC protein levels, causes diminished cytosolic Ca 2+ buffering in persAF, thereby potentiating the occurrence of spontaneous Ca 2+ release events and atrial fibrillation susceptibility. Strategies targeting intracellular buffering may represent a promising therapeutic lead in persAF management.
- 13 August 2024
- Published by Wolters Kluwer Health in Circulation
- Vol. 150 (7) , 544-559
Open AccessImpaired Intracellular Calcium Buffering Contributes to the Arrhythmogenic Substrate in Atrial Myocytes From Patients With Atrial Fibrillation
BACKGROUND: Alterations in the buffering of intracellular Ca 2+ , for which myofilament proteins play a key role, have been shown to promote cardiac arrhythmia. It is interesting that although studies report atrial myofibrillar degradation in patients with persistent atrial fibrillation (persAF), the intracellular Ca 2+ buffering profile in persAF remains obscure. Therefore, we aimed to investigate the intracellular buffering of Ca 2+ and its potential arrhythmogenic role in persAF. METHODS: Transmembrane Ca 2+ fluxes (patch-clamp) and intracellular Ca 2+ signaling (fluo-3-acetoxymethyl ester) were recorded simultaneously in myocytes from right atrial biopsies of sinus rhythm (Ctrl) and patients with persAF, alongside human atrial subtype induced pluripotent stem cell–derived cardiac myocytes (iPSC-CMs). Protein levels were quantified by immunoblotting of human atrial tissue and induced pluripotent stem cell–derived cardiac myocytes. Mouse whole heart and atrial electrophysiology were measured on a Langendorff system. RESULTS: Cytosolic Ca 2+ buffering was decreased in atrial myocytes of patients with persAF because of a depleted amount of Ca 2+ buffers. In agreement, protein levels of selected Ca 2+ binding myofilament proteins, including cTnC (cardiac troponin C), a major cytosolic Ca 2+ buffer, were significantly lower in patients with persAF. Small interfering RNA (siRNA)–mediated knockdown of cTnC (si-cTNC) in atrial iPSC-CM phenocopied the reduced cytosolic Ca 2+ buffering observed in persAF. Si-cTnC treated atrial iPSC-CM exhibited a higher predisposition to spontaneous Ca 2+ release events and developed action potential alternans at low stimulation frequencies. Last, indirect reduction of cytosolic Ca 2+ buffering using blebbistatin in an ex vivo mouse whole heart model increased vulnerability to tachypacing-induced atrial arrhythmia, validating the direct mechanistic link between impaired cytosolic Ca 2+ buffering and atrial arrhythmogenesis. CONCLUSIONS: Our findings suggest that loss of myofilament proteins, particularly reduced cTnC protein levels, causes diminished cytosolic Ca 2+ buffering in persAF, thereby potentiating the occurrence of spontaneous Ca 2+ release events and atrial fibrillation susceptibility. Strategies targeting intracellular buffering may represent a promising therapeutic lead in persAF management.
- 1 August 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (4) , 923-932
Minimally invasive extracorporeal circulation versus conventional cardiopulmonary bypass in patients undergoing cardiac surgery (MiECS): Rationale and design of a multicentre randomised trial
Introduction: The ultimate answer to the question whether minimal invasive extracorporeal circulation (MiECC) represents the optimal perfusion technique in contemporary clinical practice remains elusive. The present study is a real-world study that focuses on specific perfusion-related clinical outcomes after cardiac surgery that could potentially be favourably affected by MiECC and thereby influence the future clinical practice. Methods: The MiECS study is an international, multi-centre, two-arm randomized controlled trial. Patients undergoing elective or urgent coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or combined procedure (CABG + AVR) using extracorporeal circulation will be randomized to MiECC or contemporary conventional cardiopulmonary bypass (cCPB). Use of optimized conventional circuits as controls is acceptable. The study design includes a range of features to prevent bias and is registered at clinicaltrials.gov (NCT05487612). Results: The primary outcome is a composite of postoperative serious adverse events that could be related to perfusion technique occurring up to 30 days postoperatively. Secondary outcomes include use of blood products, ICU and hospital length of stay (30 days) as well as health-related quality of life (30 and 90 days). Conclusions: The MiECS trial has been designed to overcome perceived limitation of previous trials of MiECC. Results of the proposed study could affect current perfusion practice towards advancement of patient care.
- 1 August 2024
- Published by SAGE Publications in Perfusion
- Vol. 40 (4) , 923-932
Minimally invasive extracorporeal circulation versus conventional cardiopulmonary bypass in patients undergoing cardiac surgery (MiECS): Rationale and design of a multicentre randomised trial
Introduction: The ultimate answer to the question whether minimal invasive extracorporeal circulation (MiECC) represents the optimal perfusion technique in contemporary clinical practice remains elusive. The present study is a real-world study that focuses on specific perfusion-related clinical outcomes after cardiac surgery that could potentially be favourably affected by MiECC and thereby influence the future clinical practice. Methods: The MiECS study is an international, multi-centre, two-arm randomized controlled trial. Patients undergoing elective or urgent coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or combined procedure (CABG + AVR) using extracorporeal circulation will be randomized to MiECC or contemporary conventional cardiopulmonary bypass (cCPB). Use of optimized conventional circuits as controls is acceptable. The study design includes a range of features to prevent bias and is registered at clinicaltrials.gov (NCT05487612). Results: The primary outcome is a composite of postoperative serious adverse events that could be related to perfusion technique occurring up to 30 days postoperatively. Secondary outcomes include use of blood products, ICU and hospital length of stay (30 days) as well as health-related quality of life (30 and 90 days). Conclusions: The MiECS trial has been designed to overcome perceived limitation of previous trials of MiECC. Results of the proposed study could affect current perfusion practice towards advancement of patient care.
- Open Access
- 17 November 2023
- Published by SAGE Publications in Perfusion
- Vol. 39 (8) , 1708-1714
Influence of minimal invasive extracorporeal circuits on dialysis dependent patients undergoing cardiac surgery
Introduction: Cardiac surgery in patients on chronic renal dialysis is associated with significant morbidity and mortality. Minimally invasive extracorporeal circuits (MiECC) have shown a positive impact on patient outcome in different high-risk populations. This retrospective study compares the outcome of these high-risk patients undergoing heart surgery either with a MiECC or a conventional extracorporeal circulation (CECC). Methods: This is a single-center experience including 131 consecutive dialysis dependent patients undergoing cardiac surgery between January 2006 and December 2016. A propensity score matching was employed leaving 30 matched cases in each group. Results: After propensity score matching the 30-day mortality was significantly lower in the MiECC group ( n = 3 (10%) vs n = 10 (33%) in the CECC group, p = .028). Further, intraoperative transfused units of packed red blood cells were lower in the MiECC group (1.4 ± 1.8 units vs 2.8 ± 1.7, p < .001). Conclusions: There are evident advantages to using MiECC in dialysis dependent patients, especially regarding mortality. These findings necessitate additional research in MiECC usage in high-risk populations.
- 17 November 2023
- Published by SAGE Publications in Perfusion
- Vol. 39 (8) , 1708-1714
Open AccessInfluence of minimal invasive extracorporeal circuits on dialysis dependent patients undergoing cardiac surgery
Introduction: Cardiac surgery in patients on chronic renal dialysis is associated with significant morbidity and mortality. Minimally invasive extracorporeal circuits (MiECC) have shown a positive impact on patient outcome in different high-risk populations. This retrospective study compares the outcome of these high-risk patients undergoing heart surgery either with a MiECC or a conventional extracorporeal circulation (CECC). Methods: This is a single-center experience including 131 consecutive dialysis dependent patients undergoing cardiac surgery between January 2006 and December 2016. A propensity score matching was employed leaving 30 matched cases in each group. Results: After propensity score matching the 30-day mortality was significantly lower in the MiECC group ( n = 3 (10%) vs n = 10 (33%) in the CECC group, p = .028). Further, intraoperative transfused units of packed red blood cells were lower in the MiECC group (1.4 ± 1.8 units vs 2.8 ± 1.7, p < .001). Conclusions: There are evident advantages to using MiECC in dialysis dependent patients, especially regarding mortality. These findings necessitate additional research in MiECC usage in high-risk populations.